Feedback / Questions
vimirogant (VTP-43742) - AbbVie
Vitae Pharmaceuticals: Wedbush PacGrow Healthcare Conference
(Vitae Pharma)
-
Aug 20, 2016 -
Anticipated patent protection until 2035
Anticipated patent expiry
•
Psoriasis
http://wsw.com/webcast/wedbush32/vtae/
Aug 20, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious